Abstract:OBJECTIVES:Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in China and, due to the limited efficacy of currently available therapies, is responsible for a large number of deaths. IFN-alpha therapy has shown promise in the treatment of various forms of human cancer and is considered in the treatment of HCC. Previous results from our group showed that high doses of IFN-alpha exert a significant antiproliferative effect on MHCC97 human xenografts in nude mice, but not on MHCC97 cells when tested in vitro. Here we present experiments designed to characterize the molecular mechanism underlying the defective response of MHCC97 cells to IFN-alpha. Elucidation of the mechanism underlying the defective response of MHCC97 to IFN-alpha may help to explain and possibly to overcome clinical failures of this form of tumor therapy.METHODS:IFN-alpha(2a) was administered between 3,000 and 10,000 IU/ml, a range strongly inhibiting proliferation in other cell lines. Gene expression profiles of MHCC97 cells were obtained before and after treatment with IFN-alpha(2a) using cDNA microarray analysis. The transcriptional activity of relevant genes responding to IFN-alpha(2a) in the cDNA microarray experiments was confirmed by RT-PCR and Northern blot analysis. Transient transfection with an expression vector was used to restore p48-ISGFgamma (IRF9) protein levels. Cell proliferation was evaluated using the MTT assay.RESULTS:Although IFN-alpha treatment caused the activation of several signal transduction pathways in MHCC97 cells, the lack of an antiproliferative effect was found to mainly derive from a defect in the activation of the transcription factor ISGF3 required for Jak/STATS signaling. We show that the defect in ISGF3 activation is mainly caused by the absence of one of its essential components, the protein p48-ISGFgamma from MHCC97 cells. Indeed, transient expression of p48-ISGFgamma restores sensitivity to IFN-alpha(2a). Although the mRNA levels of p48-ISGFgamma were normal in MHCC97 cells, mutations could be detected in the gene coding for the protein. We hypothesize, therefore, that these mutations alter the message or protein stability, leading to the reduced protein levels observed.CONCLUSION:Our results confirm the important role of Jak/STATS signaling in the antiproliferative effects of IFN-alpha in tumor cells and indicate that defects in ISGF3 can cause resistance to IFN-alpha(2a) treatment.

Study on the Tumor Cells Anti-Proliferation Effect of PEG-IFNα2b

[Effect of recombinant super-compound interferon (rSIFN-co) on human breast cancer cells in vitro].

Effects of IFN-α2b on Telomerase Activity and the Toxic Effects to Cultured Choroidai Melanoma of Human Eves

Study on the Effect of Pegylatied Recombinant Consensus Interferon on Immuno-Function in Mice

Pegylated Interferon-α2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo

Interferon induced transmembrane protein 1 with interferon α synergistically inhibited proliferation of colorectal cancer cell line SW480

The clinical analysis of PEG-interferon alpha-2b therapy in 61 cases of HBeAg-positive chronic hepatitis B

Anti-tumor Effects of Exosomes Derived from Tumor Cells Modified by IFN-γ Gene

Intratumoral Injection of Interferon Gamma Promotes the Efficacy of Anti-Pd1 Treatment in Colorectal Cancer

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

Comparison of Anti-Proliferation Effects of Two IFNs on Tca8113,ACC-Min Vitro

Impact of Interferon-alpha1b (IFN-α1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma

The Effect of Interferon-β on Endothelial Progenitor Cell-induced Tumor Angiogenesis

PEGylation of Human Interferon-Α2b with Modified Amino Acids Increases Circulation Half-Life and Antiproliferative Activity

Anti-tumor Effect of IFNγ Endostatin Gene-Radiotherapy in Vivo and Its Mechanism

Therapeutic Efficacy of Bifidobacterium Longum-Mediated Human Interleukin-2 with Endostatin or Trail in Transplanted Tumors in Mice

Effect of antisense gene of type Ⅱ insulin-like growth factor receptor on malignant phenotype of human hepatoma cells in vitro

A Multicenter, Randomized, Open-Label Study of the Safety and Effectiveness of Pegylated Interferon Alpha 2b and Interferon Alpha 2b in Treating HBeAg Positive Chronic Hepatitis B Patients

Pegylation and Cell Based Bioassay of Human Interferon-Α2b along Its Docking Studies and Effect on Plasma Half-Life.

Reduction in P48-Isgfgamma Levels Confers Resistance to Interferon-Alpha2a in MHCC97 Cells.

[Effects of Interferon-Gamma Combined with All-Trans Retinoic Acid on Proliferation and Differentiation of Leukemia Cell Lines NB4 and MR2].